A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in ...

DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s ...

One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...

Shares of DexCom Inc. DXCM shed 1.38% to $67.79 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.21% to 6,781.48 and Dow ...

DexCom, Inc. (DXCM) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 1:05 PM ESTCompany ParticipantsJereme Sylvain - Executive ...

But what if companies outside of the pharmaceutical industry benefit as well? One excellent candidate to do so is DexCom ...

DexCom is also increasingly targeting non-diabetic patients, notably with newer over-the-counter products in the U.S. such as Stelo, which received clearance in 2024 and has attracted over half a ...

We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now. On February 13, Mizuho analyst ...

DexCom’s fourth quarter results reflected ongoing momentum in both product innovation and international expansion. Management attributed the quarter’s performance to the broad rollout of the G7 15-day ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

The "Glucose Goddess" built a brand around her blood sugar balancing hacks. She said a few swaps to her diet boosted her mood ...

Out of the diabetes patients surveyed, 46% said they would feel more in control of their disease in everyday life if they ...